Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 904

1.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
2.

Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

Sievers M, Walker UA, Sevastianova K, Setzer B, Wågsäter D, Eriksson P, Yki-Järvinen H, Sutinen J.

J Infect Dis. 2009 Jul 15;200(2):252-62. doi: 10.1086/599986.

PMID:
19519254
3.

Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.

Buffet M, Schwarzinger M, Amellal B, Gourlain K, Bui P, Prévot M, Deleuze J, Morini JP, Gorin I, Calvez V, Dupin N.

J Clin Virol. 2005 May;33(1):60-4.

PMID:
15797366
4.

Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.

Pace CS, Martin AM, Hammond EL, Mamotte CD, Nolan DA, Mallal SA.

Antivir Ther. 2003 Aug;8(4):323-31.

PMID:
14518702
5.

Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Nolan D, Hammond E, James I, McKinnon E, Mallal S.

Antivir Ther. 2003 Dec;8(6):617-26.

PMID:
14760896
6.

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S.

AIDS. 2003 Jun 13;17(9):1329-38.

PMID:
12799554
8.

Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.

Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, Girard PM, Levan P, Rozenbaum W, Lombès A, Capeau J, Bastard JP.

Antivir Ther. 2004 Aug;9(4):555-64.

PMID:
15456087
10.

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV.

J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. Review.

PMID:
14562863
11.

A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.

Kim MJ, Leclercq P, Lanoy E, Cervera P, Antuna-Puente B, Maachi M, Dorofeev E, Slama L, Valantin MA, Costagliola D, Lombes A, Bastard JP, Capeau J.

Antivir Ther. 2007;12(8):1273-83.

PMID:
18240867
12.

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.

Vigouroux C, Maachi M, Nguyên TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP.

AIDS. 2003 Jul 4;17(10):1503-11.

PMID:
12824788
13.

Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.

Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, Shiramizu B.

AIDS. 2001 Sep 28;15(14):1801-9.

PMID:
11579242
14.

Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.

Maisonneuve C, Igoudjil A, Begriche K, Lettéron P, Guimont MC, Bastin J, Laigneau JP, Pessayre D, Fromenty B.

Antivir Ther. 2004 Oct;9(5):801-10.

PMID:
15535418
15.
16.

In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis.

Miró O, Villarroya J, Garrabou G, López S, Rodríguez de la Concepción M, Pedrol E, Martínez E, Giralt M, Gatell JM, Cardellach F, Casademont J, Villarroya F.

Antivir Ther. 2005;10(8):945-51.

PMID:
16430200
17.

HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.

Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepción ML, Alegre M, Domingo JC, Villarroya F.

Antivir Ther. 2006;11(6):729-40.

PMID:
17310817
18.

Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.

Hammond E, McKinnon E, Nolan D.

Clin Infect Dis. 2010 Sep 1;51(5):591-9. doi: 10.1086/655765.

PMID:
20645860
19.

Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients.

Ciccosanti F, Corazzari M, Soldani F, Matarrese P, Pagliarini V, Iadevaia V, Tinari A, Zaccarelli M, Perfettini JL, Malorni W, Kroemer G, Antinori A, Fimia GM, Piacentini M.

Antivir Ther. 2010;15(3):377-90. doi: 10.3851/IMP1530.

PMID:
20516557
20.

The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients.

Gilleece Y, Torti C, Mandalia S, Gazzard BG, Pillay D, Pozniak AL.

HIV Med. 2003 Oct;4(4):305-10.

Supplemental Content

Support Center